US FDA expands J&J's psoriasis drug for inflammatory bowel disease: The U.S. Food and Drug Administration has allowed the expanded use of Johnson & Johnson's ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-expands-jjs-psoriasis-drug-inflammatory-bowel-disease-2024-09-11/
Quick Glance: FDA Approves Tremfya for Inflammatory Bowel Disease
- The U.S. FDA has approved the expanded use of Johnson & Johnson's drug Tremfya for adults with chronic inflammatory bowel disease.
- This approval provides an additional treatment option for patients suffering from ulcerative colitis.
- J&J is betting on Tremfya as a key product since its other major drug, Stelara, faces a patent expiration.
- Analysts forecast Stelara sales exceeding $10 billion this year, with 75% expected from inflammatory bowel disease treatments.
Veteran fund manager views Warren Buffett moves as worrisome: The S&P 500 stock index has climbed 16% year to date.
thestreet.com/investing/stocks/fund-manager-buffett-moves-worrisome
"I can and will reclaim my life one step at a time...Battle a shark, lose a limb, work to recover, make the Paralympics and medal, all in a year ... Show more
Forbes Power Women’s Summit 2024: Inside The Leaders Shaping Your Health, Wealth And Entertainment
Forbes Power Women’s Summit 2024: Inside The Leaders Shaping Your Health, Wealth And Entertainment
Johnson & Johnson plans to pay an additional $1.1 billion to resolve tens of thousands of legal actions alleging its baby powder and other talc products ... Show more
Johnson & Johnson adds $1.1 billion to proposed talc settlement | Reuters
Johnson & Johnson adds $1.1 billion to proposed talc settlement | Reuters
Quick Glance: Johnson & Johnson Increases Talc Settlement by $1.1 Billion
- Johnson & Johnson plans to pay an additional $1.1 billion to settle tens of thousands of lawsuits alleging its talc products caused cancer.
- This increase would raise the total settlement amount to over $9 billion paid over 25 years.
- A J&J subsidiary is set to declare bankruptcy to finalize the settlement, allowing the parent company to continue operations without filing for Chapter 11.
- Some lawyers representing cancer victims oppose J&J's settlement plan and are actively contesting it.
Biden Drug Pricing Law Threatens New Products, J&J’s Duato Says: The Biden administration’s drug-price negotiation law threatens new product development and will ...
bloomberg.com/news/articles/2024-09-12/biden-drug-pricing-law-threatens-new-products-j-j-s-duato-says
Paid articlePaywall
Court tells Johnson & Johnson to pay $1 billion more for 2019 robotics deal: This appears to be the largest legal reward ever granted in an investor earnout ...
axios.com/2024/09/05/johnson-and-johnson-billion-court-auris
Compassionate Conversations in Postpartum Depression: The Diagnosis and Referral Pathway
medscape.org/viewarticle/1000860
SC man gets $63M in baby powder cancer case. With months to live – and no money yet – he speaks out.
postandcourier.com/columbia/news/sc-man-cancer-lawsuit-johnson-and-johnson-baby-powder/article_35ec522e-6ef3-11ef-9eb6-471ed2277f13.html
The Beautiful Mystery of Rooting for Aaron Rodgers: Zach Helfand writes about Aaron Rodgers, the New York Jets, the N.F.L., and fandom.
newyorker.com/culture/the-weekend-essay/the-beautiful-mystery-of-rooting-for-aaron-rodgers
Fix ‘lao hua yan’ without reading glasses: How multifocal contact lenses can help presbyopia
straitstimes.com/singapore/health/johnson-and-johnson-how-to-fix-lao-hua-yan-without-reading-glasses-acuvue-multifocal-contact-lenses-for-presbyopia
Tylenol maker defeats lawsuit over labeling: The maker of Tylenol defeated a lawsuit by consumers who said they were deceived into overpaying for "Rapid Release" ...
reuters.com/legal/tylenol-maker-defeats-lawsuit-over-labeling-2024-08-28/
The hard-partying lawyers who get negligent companies to pay billions: Mass torts hold companies accountable for their actions — but they're a product of pure ...
businessinsider.com/mass-torts-lawsuits-lawyers-settlements-strippers-hard-partying-money-2024-9
Better than shares in Coca-Cola and Johnson & Johnson? You have to know this dividend monster
boerse-online.de/nachrichten/aktien/besser-als-aktien-von-coca-cola-und-johnson-johnson-dieses-dividenden-monster-muessen-sie-kennen-20364957.html
5 Facial Spots In Johor Bahru Worth Crossing The Causeway For: Whether you're planning a weekend vacation or a short staycation, these five facial spots in JB ...
elle.com.sg/beauty/best-facial-spots-johor-bahru/
Surgery robots the goal for Medtronic in new Boston headquarters: The medical device maker hopes its proximity to universities and doctors gives it an edge over ...
bostonglobe.com/2024/08/28/business/medtronic-hugo-robot-headquarters/
Rinse with Öko-Test: Three mouthwashes are "inadequate" - | including Listerine: Mouthwashes can counteract tooth decay, plaque and gingivitis and thus ...
n-tv.de/ratgeber/Drei-Mundspuelungen-sind-ungenuegend-auch-Listerine-article25181992.html
Ron Johnson has mysteries of Kennedy, Nixon and Trump solved. It's the deep state's fault.
jsonline.com/story/opinion/readers/2024/09/14/donald-trump-ron-johnson-shooting-conspiracy-deep-state/75213700007/
Kenvue launches global influencer agency review: Kenvue has recently made a series of agency changes.
adage.com/article/agency-news/kenvue-launches-global-influencer-agency-review/2579901
Paid articlePaywall
Sumitomo U.S. unit files for bankruptcy on talc lawsuit expenses : TOKYO -- A U.S. subsidiary of Japanese trading house Sumitomo Corp. that distributed cosmetics ...
asia.nikkei.com/Business/Companies/Sumitomo-U.S.-unit-files-for-bankruptcy-on-talc-lawsuit-expenses
Paid articlePaywall
Omaha neighbors: Obituaries for September 2: Read through the obituaries published today in Omaha World-Herald.
omaha.com/news/local/omaha-neighbors-obituaries-for-september-2/collection_73f1d0f6-c9a9-511e-864b-731fbe24dac8.html
An Ode to .. to the Minister of Cutting Red Tape, Seymour of the Grand Scissors: Bard Billot on the poobah of thinking small
newsroom.co.nz/2024/09/01/an-ode-to-to-the-minister-of-cutting-red-tape-seymour-of-the-grand-scissors/
Why corporate names are so hard to change: A new name can't just be announced.
axios.com/2024/09/03/why-corporate-names-are-so-hard-to-change
Competition law has again worked to fight a bad drug patent, but we need other solutions
dailymaverick.co.za/article/2024-09-02-competition-law-has-again-worked-to-fight-a-bad-drug-patent-but-we-need-other-solutions/
Skincare Labor Day Deals 2024: Get Up To 63% Off Beauty At Sephora, Ulta, And More
womenshealthmag.com/beauty/a61996069/skincare-labor-day-deals-2024/
Johnson & Johnson names new general manager for Irish commercial operation : Michaela Hagenhofer will pay special focus to driving sustainable growth through ...
businesspost.ie/news/johnson-johnson-names-new-general-manager-for-irish-commercial-operation/
Paid articlePaywall
PS5 Pro Reportedly Still Releasing This Year: Just rip the Band-Aid off already!
thegamer.com/sony-playstation-5-pro-reportedly-still-releasing-in-2024-next-generation-hardware-refresh/
If I Could Only Buy 2 High Dividend Yield Companies In August 2024: Discover two high dividend yield companies with strong financials and growth potential ...
seekingalpha.com/article/4717191-if-i-could-only-buy-2-high-dividend-yield-companies-in-august-2024
Paid articlePaywall
President Biden and Vice President Kamala Harris celebrated the results of landmark price negotiations between Medicare and pharmaceutical companies ... Show more
U.S. Unveils Price Limits for 10 Costly or Common Medications - The New York Times
U.S. Unveils Price Limits for 10 Costly or Common Medications - The New York Times
Quick Glance: Medicare Drug Prices Significantly Reduced
- The Biden administration has reached agreements with pharmaceutical companies to lower the prices of ten of Medicare's most expensive and popular drugs. These medications, which cost $50 billion annually, affect millions of older Americans who rely on them for diabetes treatment, blood cancers, and heart failure prevention.
- It is projected that the new prices will save U.S. taxpayers $6 billion and older Americans approximately $1.5 billion. However, specific details about the new prices have yet to be released, and the estimates are based on outdated data.
- These agreements represent a significant advancement for the Medicare program, which serves over 67 million older and disabled Americans. Until now, the federal government was prohibited from negotiating drug prices with pharmaceutical companies, resulting in excessively high costs.
- The new prices are expected to take effect in 2026, with the Centers for Medicare and Medicaid Services set to announce the final prices later. Next year, the Department of Health and Human Services can negotiate prices for an additional 15 drugs, while Vice President Kamala Harris will highlight this initiative as a key part of her presidential campaign.
Women injured by vaginal mesh in England get payout: More than 100 women who experienced complications have received payouts from manufacturers.
bbc.com/news/articles/clylng1dqx2o
The Biden administration released the prices of the first-ever negotiated Medicare Part D prescription drugs. The yearlong negotiation process will yield ... Show more
Medicare to save $6B in 2026 from the first ever Part D drug pricing negotiations
Medicare to save $6B in 2026 from the first ever Part D drug pricing negotiations
Johnson & Johnson has overcome a major hurdle for its $6.5 billion settlement over lawsuits alleging its baby powder and other talc products caused cancer ... Show more
J&J has enough support from claimants for $6.5-billion talc settlement, Bloomberg reports | Reuters
J&J has enough support from claimants for $6.5-billion talc settlement, Bloomberg reports | Reuters
U.S. Unveils Price Limits for 10 Costly or Common Medications: The Biden administration said it would have saved $6 billion had the new prices been in effect ...
nytimes.com/2024/08/15/us/politics/us-to-announce-prices-for-first-drugs-picked-for-medicare-negotiations.html
J&J to buy medical device maker V-Wave for up to $1.7 bln: Johnson & Johnson said on Tuesday it would buy medical device maker V-Wave for up to $1.7 billion ...
reuters.com/markets/deals/jj-buy-medical-device-maker-v-wave-up-11-bln-deal-2024-08-20/
Aaron Rodgers says he regrets making comment about being 'immunized': In an unauthorized biography, Aaron Rodgers said he regrets misleading comments made in ...
usatoday.com/story/sports/nfl/jets/2024/08/12/aaron-rodgers-regrets-immunized-comment-covid/74767002007/
Quick Glance: Aaron Rodgers Regrets 2021 'Immunized' Comment
- Three years after stating he was 'immunized' against COVID-19, Aaron Rodgers admits regret for not being truthful. The quarterback explains that due to his image and critics' feedback, he made the false claim.
- In November 2021, Rodgers, a four-time league MVP for the Green Bay Packers, tested positive for COVID-19 as an unvaccinated player, facing widespread criticism for misleading remarks and a rejected vaccine qualification appeal.
- Rodgers revealed his treatment was due to an allergy to vaccine ingredients and concerns over adverse reactions. He acknowledged he should have handled the situation differently and expressed regret over his vaccination decisions.
- Additional details within the book explore Rodgers' family dynamics, disappointment over the 2014 NFC Championship Game, and other aspects of his personal and professional life. The book is set to be released next week.
Tennessee's parental consent law may prevent school nurses from performing basic functions without permission
newschannel5.com/news/tennessees-parental-consent-law-may-prevent-school-nurses-from-performing-basic-functions-without-permission
J&J's chemotherapy-free treatment for lung cancer gets US approval: The U.S. Food and Drug Administration on Tuesday approved Johnson & Johnson's ...
reuters.com/business/healthcare-pharmaceuticals/us-fda-approves-jjs-combination-therapy-type-lung-cancer-2024-08-20/
#GraziaBeauty Creation and innovation are evergreen in the beauty department. With that in mind, these are the hottest launches on our radar right now ... Show more
Weekly Edit: 6 New Beauty Launches We're Crushing On RN | Grazia India
Weekly Edit: 6 New Beauty Launches We're Crushing On RN | Grazia India
Acuerdan baja de precios para 10 medicamentos caros y comunes en EE. UU.: Los precios fueron posibles gracias a la Ley de Reducción de la Inflación ...
nytimes.com/es/2024/08/16/espanol/precios-farmacos-medicare-2026.html
Listerine-maker Kenvue beats estimates on strong essential health product sales: Kenvue beat Wall Street estimates for second-quarter profit and revenue on ...
reuters.com/business/healthcare-pharmaceuticals/listerine-maker-kenvue-beats-estimates-strong-essential-health-product-sales-2024-08-06/
The Uncertain Path Forward for Psychedelic Medicine: After the FDA rejected its proposed MDMA treatment, Lykos Therapeutics is laying off 75 percent of its staff ...
wired.com/story/where-does-psychedelic-assisted-therapy-go-next-mdma-fda-lykos/
Here Are the Five Health and Wellness Tools Everyone Needs Now: Prevention is key to health and wellness. Don’t wait too late to have these simple ...
scientificamerican.com/article/here-are-the-five-health-and-wellness-tools-everyone-needs-now/
Everything you need to prepare for wildfires, earthquakes, hurricanes and tornadoes, according to experts | CNN Underscored
cnn.com/cnn-underscored/reviews/natural-disaster-preparation-supplies
What are multifocal contact lenses and how do they correct presbyopia?: Multifocal contact lenses may be an alternative for those grappling with myopia and ...
cnalifestyle.channelnewsasia.com/wellness/presbyopia-multifocal-contact-lenses-394596
The best first aid kits in 2024, tried and tested | CNN Underscored: A dedicated first aid kit makes it easier to grab emergency supplies in a crisis ...
cnn.com/cnn-underscored/reviews/best-first-aid-kits
Boards Need a New Approach to Technology: The boards of too many publicly traded companies are downright timid when considering matters involving science and ...
hbr.org/2024/09/boards-need-a-new-approach-to-technology
Consumer giants from Starbucks to General Mills have one big sales problem: China
cnbc.com/2024/08/07/us-consumer-giants-have-one-big-sales-problem-china.html
Over a million square feet of prime real estate is collecting dust across New York City. It could stay that way for years. Vacant Pharmacies Are Holding Back NYC Retail - The New York Times
10 drugmakers that rule the pharmaceutical industry: Johnson & Johnson and Roche topped S&P Global's ratings for the strongest pharma companies in the world
qz.com/s-p-global-pharma-ratings-1851622593
FDA Rejection of MDMA Therapy Isn’t End of Psychedelic-Drug Candidates: The Food and Drug Administration rejected Lykos’ application to treat PTSD with MDMA ...
barrons.com/articles/fda-mdma-psychedelic-drugs-stocks-c70286ff
Paid articlePaywall
Kenvue Beats Sales Estimates, Bucking Consumer Goods Trend: Kenvue Inc., the owner of the Tylenol and Neutrogena brands, reported sales that topped estimates ...
bloomberg.com/news/articles/2024-08-06/kenvue-beats-sales-estimates-bucking-consumer-goods-trend
Paid articlePaywall
Can mouthwashes containing alcohol cause cancer?: Alcohol consumption increases the risk of oral cancer. This also applies to mouthwashes ...
stern.de/gesundheit/koennen-mundspuelungen-mit-alkohol-krebs-verursachen--34939510.html
Johnson & Johnson 2024 Q2 - Results - Earnings Call Presentation: The following slide deck was published by Johnson & Johnson in conjunction with their 2024 Q2 ...
seekingalpha.com/article/4704553-johnson-and-johnson-2024-q2-results-earnings-call-presentation
Paid articlePaywall
J&J beats Wall St estimates on strong drug sales ahead of Stelara competition: Johnson & Johnson beat estimates for second-quarter profit and revenue on ...
reuters.com/business/healthcare-pharmaceuticals/jj-beats-wall-street-estimates-strong-drug-sales-2024-07-17/
The Moisturizer That Reviewers Call A ‘Miracle In A Jar’ Is Less Than $13: With more than 67,700 5-star ratings, this is definitely one moisturizer worthy of ...
huffpost.com/entry/neutrogena-hydro-boost-amazon_l_66ab9fbbe4b037c1f37e40df
Reckitt gives weak scrub to valuation stain: Reckitt Benckiser CEO Kris Licht is giving his firm’s valuation stain a gentle scrub. The 31 billion pound Durex ...
reuters.com/breakingviews/reckitt-gives-weak-scrub-valuation-stain-2024-07-24/
Dividends have been increased for over 60 years in a row: billionaires now swear by these dividend stocks
boerse-online.de/nachrichten/zertifikate/ueber-100-jahre-ausschuettungen-auf-diese-dividenden-giganten-schwoeren-jetzt-die-milliardaere-20362095.html
J&J (JNJ) Loses Latest Legal Bid to Revive Talc Bankruptcy Strategy: Johnson & Johnson lost its bid in a federal appeals court to revive a plan to settle ...
bloomberg.com/news/articles/2024-07-25/j-j-loses-latest-legal-bid-to-revive-talc-bankruptcy-strategy
Paid articlePaywall
Johnson & Johnson Earnings Are Coming. It Took Steps to Put Its Talc Issues Behind It.
barrons.com/articles/johnson-johnson-earnings-stock-price-3bddce00
Paid articlePaywall
Everything We Know About Wake Up Dead Man: A Knives Out Mystery (Filming has wrapped)
joblo.com/everything-we-know-wake-up-dead-man/
Wall Street Breakfast: The Week Ahead: Stay informed with Wall Street Breakfast's daily podcast covering earnings releases, Federal Reserve updates ...
seekingalpha.com/article/4703949-wall-street-breakfast-week-ahead
Judge refuses to disqualify leading opponents of J&J's talc bankruptcy plan: A New Jersey judge on Friday rebuffed Johnson & Johnson's bid to disqualify the law ...
reuters.com/legal/legalindustry/judge-refuses-disqualify-leading-opponents-jjs-talc-bankruptcy-plan-2024-07-19/
Johnson & Johnson says its ketamine-based drug can treat depression: Spravato, a derivative of ketamine, is currently approved to be used in combination with an ...
qz.com/johnson-johnson-spravato-fda-1851601542
Paid articlePaywall
New England Patriots Should Rip off Band-Aid, Start Drake Maye: The New England Patriots and Jerod Mayo should cut the nonsense and just start rookie draft pick ...
deadspin.com/new-england-patriots-should-rip-off-band-aid-start-drake-maye/
Quick Glance: Drake Maye: The Future Quarterback of the Patriots?
- Following an impressive preseason performance, discussions are underway regarding whether Drake Maye, the third overall pick in the draft, should be the starting quarterback for the New England Patriots. During the second preseason game, Maye demonstrated promising development by completing a perfectly thrown 51-yard pass under pressure, even though it was ultimately incomplete.
- The Patriots had initially intended to ease Maye into the system, but his progress is forcing the team to reconsider. While veteran Jacoby Brissett is still expected to be the starter for Week 1, there are three main reasons supporting Maye's potential as a starter: his ability to work under pressure, his flexibility in play, and his strength in deep passing.
- Maye has shown an impressive ability to complete passes from various angles in crowded pockets, which could be crucial given the weaknesses in the Patriots' offensive line. Additionally, coach Alex Van Pelt adapted the playbook for Maye, incorporating plays that align better with his strengths, such as run-pass options and zone reads.
- While there are pros and cons to starting Maye right away, there are arguments in favor of him learning through gameplay. However, the challenging matchups in the first few weeks could hinder his progress. Ultimately, the decision on who will be the starter is likely to come after the final preseason game against Washington.
New drug in Giessen in test phase: An international clinical study shows the potential of nipocalimab against fetal anemia. The drug is being tested at the ...
giessener-anzeiger.de/stadt-giessen/neues-medikament-in-giessen-in-testphase-93256973.html
No Band-Aid for the Ocean Beach Pier: City won’t reopen crumbling icon before full renewal project
latimes.com/california/story/2024-08-23/no-band-aid-for-the-ocean-beach-pier-city-wont-reopen-crumbling-icon-before-full-renewal-project
Johnson & Johnson: The Dividend King Is Back: Johnson & Johnson is regaining momentum with strong growth in its innovative segments, making it an attractive ...
seekingalpha.com/article/4716746-johnson-and-johnson-the-dividend-king-is-back
Paid articlePaywall
Johnson & Johnson wins FDA approval for first chemotherapy-free lung-cancer treatment
trib.al/py19tr5
Johnson & Johnson: Don't Bet Against Double Compounding: Johnson & Johnson investors should focus on total returns, which include dividends but also EPS growth ...
seekingalpha.com/article/4716497-johnson-and-johnson-dont-bet-against-double-compounding
Paid articlePaywall
Medicare announces lower prices on 10 common drugs: What’s included and what they will cost
al.com/news/2024/08/medicare-announces-lower-prices-on-10-common-drugs-whats-included-and-what-they-will-cost.html
Large office block could become over 100 flats: A large office block in Wokingham Without formerly used as offices for Johnson and Johnson could be converted ...
bracknellnews.co.uk/news/24533038.large-office-block-become-100-flats/
Stock futures are little changed after Dow posts best day since June 2023: Live updates
cnbc.com/2024/07/16/stock-market-today-live-updates.html
Hailee Steinfeld Learned You Start To Lose Collagen In Your 20s—And Totally Overhauled Her Skincare Routine
womenshealthmag.com/beauty/a61839332/hailee-steinfeld-preaging-neutrogena/
J&J to acquire V-Wave for up to $1.7 billion in play for heart-failure device: The device, which can be inserted through a minimally invasive catheter-based ...
marketwatch.com/story/j-j-to-acquire-v-wave-for-up-to-1-7-billion-in-play-for-heart-failure-device-d2e8fff0
Johnson & Johnson Gets FDA Approval for Treatment, Makes Acquisition of Up to $1.7 Billion
barrons.com/articles/johnson-johnson-fda-approval-acquisition-95d2ba8a
Paid articlePaywall
Neutrogena releases Hydro Boost skincare line - Trinidad and Tobago Newsday: WOMEN are rediscovering the Neutrogena Hydro Boost line. Local distributor Smith ...
newsday.co.tt/2024/08/18/neutrogena-releases-hydro-boost-skincare-line/
The Makeup Removers 'RuPaul's Drag Race' Queens Keep in Their Beauty Bags: Just between us squirrel friends, six queens spill the tea on their favorite makeup ...
fashionista.com/2024/08/makeup-removers-drag-queens-use-wipes-cleansing-balms
Stocks Are on a Record-Setting Tear. Where They Go From Here and 4 Other Things to Know Today.
barrons.com/articles/stock-markets-what-to-know-today-352dbd73
Paid articlePaywall
A new weight loss pill, Ozempic boosts protein sales, J&J's cancer drug: Pharma news roundup
qz.com/roche-weight-loss-drug-pill-ozempic-1851599142
Emergent, J&J settle COVID vaccine supply deal dispute: Emergent BioSolutions said on Monday Johnson & Johnson has agreed to pay $50 million to settle claims ...
reut.rs/3xGaNJM
SC man who said Johnson & Johnson baby powder gave him cancer awarded $63M by jury
postandcourier.com/columbia/news/johnson-and-johnson-cancer-lawsuit-south-carolina/article_6801b478-5bd1-11ef-baf1-dbd8c3920b39.html
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics